About

LENISNA is a hybrid filler which have connected both benefits of immediate filling efect of HA (hyaluronic acid) and long-term stimulation of collagen production by PDLLA (Poly D,L – lactide).

Thanks to the patented manufacturing technology, patent no. 10-1481441, no. 10-1725279, a preparation with unique properties has been created: long-lasting effectiveness and an increased safety profile.

LENISNA is designed as a time-acting filler with a concentration of 170 mg of PDLLA polylactic acid, and 30 mg of non-cross-linked hyaluronic acid. By adjusting the amount of the solution and the particle size from 50 to 60 micrometers and combining them with non-cross-linked hyaluronic acid, a hybrid was obtained that is suitable for application in subcutaneous or periosteal tissue.

It is intended for the treatment of deep wrinkles, laxity and significant tissue defects.

WOW EFFECT! Thanks to the combination of PDLLA polylactic acid with HA hyaluronic acid, we obtain an effect that is visible immediately after the treatment.

The filling is maintained until the production of new collagen, elastin, by polylactic acid begins to dominate.

What makes LENISNA unique?

• its ability to stimulate collagen production in the strongest possible way and restore youthful appearance in a gradual and natural way.
• no need to massage the post-treatment areas due to the round shape of PDLLA acid molecules and its combination with non-cross-linked hyaluronic acid.
• the durability of the treatment lasts over 24 months from the last treatment. The effect can be sustained by performing 1 reminder treatment after 24 months.

Indications

Due to the high concentration of poly D,L lactic acid – 170 mg and hyaluronic acid – 30 mg, the treatment is intended for people:

• with clear signs of aging 40 +
• needing to increase the volume of sunken areas of the face
• especially for the correction of skin depressions such as: folds in the skin, wrinkles, furrows, as well as in the case of face drooping and skin laxity